The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Industry s Direct’s proprietary databases, Firms ’s corporate website, SEC filings, investor presentations and featured press releases, both from industry player and market -specific third party sources, put together by Global Industry s Direct’s team.

Scope of the Research

- Massachusetts Eye and Ear Infirmary - Brief industry player overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Massachusetts Eye and Ear Infirmary human therapeutic division.
- Detailed Analysis of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Massachusetts Eye and Ear Infirmary with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Massachusetts Eye and Ear Infirmary’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Why Should You Get This Report?

- Evaluate Massachusetts Eye and Ear Infirmary’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Massachusetts Eye and Ear Infirmary in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Massachusetts Eye and Ear Infirmary’s Research and Development portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Massachusetts Eye and Ear Infirmary.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Massachusetts Eye and Ear Infirmary and identify potential opportunities in those areas.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Massachusetts Eye and Ear Infirmary Snapshot 5
Massachusetts Eye and Ear Infirmary Overview 5
Key Information 5
Key Facts 5
Massachusetts Eye and Ear Infirmary - Research and Development Overview 6
Key Therapeutic Areas 6
Massachusetts Eye and Ear Infirmary - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Combination Treatment Modalities 11
Massachusetts Eye and Ear Infirmary - Pipeline Products Glance 12
Massachusetts Eye and Ear Infirmary - Late Stage Pipeline 12
Phase III Products/Combination Treatment Modalities 12
Massachusetts Eye and Ear Infirmary Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Massachusetts Eye and Ear Infirmary - Drug Profiles 15
Methylprednisolone Sodium Succinate 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
Prednisone 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
Propranolol 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
Proton Pump Inhibitor 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
2.5% Interleukin-1-Receptor Antagonist 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
5% Interleukin-1-Receptor Antagonist 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
Avastin 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
IL-1Ra 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
ranibizumab 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
Ranibizumab + Proton Beam Irradiation 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
Massachusetts Eye and Ear Infirmary - Pipeline Analysis 25
Massachusetts Eye and Ear Infirmary - Pipeline Products by Therapeutic Class 25
Massachusetts Eye and Ear Infirmary Pipeline Products By Target 27
Massachusetts Eye and Ear Infirmary - Pipeline Products by Route of Administration 29
Massachusetts Eye and Ear Infirmary - Pipeline Products by Molecule Type 31
Massachusetts Eye and Ear Infirmary - Locations And Subsidiaries 32
Head Office 32
Recent Developments 33
March 29, 2010: Health Canada Approves Roche's AVASTIN For Treatment Of Glioblastoma Multiforme 33
March 29, 2010: Health Canada Approves Roche's AVASTIN For Treatment Of Glioblastoma Multiforme 33
March 15, 2010: Roche's Phase III study Of Avastin In Men With Late Stage Prostate Cancer Fails Endpoint 34
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 36
Contact Us 36
Disclaimer 36List of Tables
Massachusetts Eye and Ear Infirmary - Pipeline by Therapy Area and Indication, 2010 8
Massachusetts Eye and Ear Infirmary - Pipeline by Stage of Development, 2010 9
Massachusetts Eye and Ear Infirmary - Monotherapy Products in Pipeline, 2010 10
Massachusetts Eye and Ear Infirmary - Combination Treatment Modalities in Pipeline, 2010 11
Massachusetts Eye and Ear Infirmary - Phase III, 2010 12
Massachusetts Eye and Ear Infirmary - Phase II, 2010 13
Massachusetts Eye and Ear Infirmary - Phase I, 2010 14
Massachusetts Eye and Ear Infirmary - Pipeline By Therapeutic Class, 2010 25
Massachusetts Eye and Ear Infirmary - Pipeline By Target, 2010 28
Massachusetts Eye and Ear Infirmary - Pipeline By Route of Administration, 2010 30
Massachusetts Eye and Ear Infirmary - Pipeline By Molecule Type, 2010 31

List of Figures
Massachusetts Eye and Ear Infirmary - Pipeline by Therapy Area and Indication, 2010 7
Massachusetts Eye and Ear Infirmary - Pipeline by Stage of Development, 2010 9
Massachusetts Eye and Ear Infirmary - Monotherapy Products in Pipeline, 2010 10
Massachusetts Eye and Ear Infirmary - Combination Treatment Modalities in Pipeline, 2010 11
Massachusetts Eye and Ear Infirmary - Pipeline By Therapeutic Class, 2010 25
Massachusetts Eye and Ear Infirmary - Pipeline By Target, 2010 27
Massachusetts Eye and Ear Infirmary - Pipeline By Route of Administration, 2010 29
Massachusetts Eye and Ear Infirmary - Pipeline By Molecule Type, 2010 31

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Diagnostics and Therapeutics for HIV: Global Markets

Diagnostics and Therapeutics for HIV: Global Markets

  • $ 6 650
  • Industry report
  • April 2014
  • by BCC Research

STUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for products used in the treatment, testing ...

JAK and PI3K Signaling Pathway Markets

JAK and PI3K Signaling Pathway Markets

  • $ 6 650
  • Industry report
  • April 2014
  • by BCC Research

REPORT HIGHLIGHTS The global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion ...

Therapeutics for Women%s Health: Technologies and Global Markets

Therapeutics for Women%s Health: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • May 2014
  • by BCC Research

Use this report to: - Learn about the main women's health disorders and relevant disease prevalence population. - Identify the impact of demographic, economic, and other factors that will drive future ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.